Physician profile
Brent E Aebi
NPI 1902291859
$1,944.70
in general payments reported to CMS, 2019-2025
19 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $659 · 2020: $149 · 2021: $165 · 2022: $188 · 2023: $247 · 2024: $381 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $616.91 | 2019-2025 | Rocklatan, Rhopressa, Simbrinza |
| Rxsight INC | $314.52 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Glaukos Corporation | $143.62 | 2019-2024 | Idose |
| Aerie Pharmaceuticals, INC. | $114.24 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $112.86 | 2019-2020 | |
| Spark Therapeutics, INC. | $100.30 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $93.56 | 2019 | |
| Mallinckrodt Hospital Products INC. | $78.14 | 2020-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $66.24 | 2020-2021 | |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Biotissue Holdings INC. | $44.86 | 2021 | |
| Sight Sciences, INC. | $38.28 | 2024-2025 | Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $37.95 | 2019 | |
| Allergan, INC. | $29.77 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $20.89 | 2025 | Gore Enform Preperitoneal Biomaterial |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $18.63 | 2022 | |
| Shire North American Group INC | $18.42 | 2019 | |
| Vanda Pharmaceuticals INC. | $17.70 | 2020 | |
| Vantage Technology LLC | $13.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Aebi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.